That billionaire's quote is not supposed to be fol
Post# of 148185
Leronlimab is a molecule that appears to be revolutionary in terms of what it might be able to treat in humankind. CYDY is a company that cannot get its act together for the past 3 years (at least) now.
My point is that once there is good news, which we all expect, THEN new investors will be flocking to this stock and while they may not have gotten in at $.48, there will still be tons of upside. Right now, sitting on the sidelines as management tries to figure out which end is up and while we await the release of trial results (some of which we should have had weeks ago) is not a bad play. Again, there will be plenty of time to make money IF things go as we hope they will.